您的位置: 首页 > 农业专利 > 详情页

IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
专利权人:
Astellas Pharma Inc.
发明人:
Kiyohiro SAMIZU,Naoyuki MASUDA,Kazuhiko IIKUBO,Yohei KOGANEMARU,Noriyuki KAWANO,Junya OHMORI,Yasuyuki MITANI,Keni NI
申请号:
US13661601
公开号:
US20130053363A1
申请日:
2012.10.26
申请国别(地区):
US
年份:
2013
代理人:
摘要:
[Problem]To provide a compound useful as medicine having PDE4B inhibitory activity, in particular, as an active ingredient of a composition for treating or preventing schizophrenia, Alzheimer's disease, dementia, depression and the like.[Measures for Solution]The present inventors examined compounds having PDE4B inhibitory activity and found that a tricyclic or tetracyclic imidazo[1,2-a]pyridine derivative or salts thereof had a superior PDE4B inhibitory activity, thereby completing the present invention. The imidazo[1,2-a]pyridine derivative can be used as an agent for treating or preventing schizophrenia, Alzheimer's disease, dementia, depression and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充